Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 468 of 698

Advanced search

🇺🇸Jul 22Industryarrowheadpharma.comTier 1 · Company source

Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia

Deep, durable, and consistent median triglyceride reductions of 79% and 81% from baseline in SHASTA...

Arrowhead PharmaceuticalsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Enliven Therapeutics' Soaring Stock Faces a $570,000 Insider Reality Check

Kavout | AIOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

CNBCOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Aribio to Present AR1001 Phase 3 Results in First Session at CTAD 2026 Opening

아시아경제Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Trump says generic drugs to face no US tariffs for 2 years, then 100% and 200% tariffs later

ReutersOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Fervor over top-selling drugs fuels biotech dealmaking

SemaforOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Cambium Bio Raises AUD 1.008 Million via Placement to Fund Phase 3 Elate Ocular Trial

KalkineOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Radiopharm Theranostics Achieves 93% Concordance in Phase 2b Trial of RAD101 for Brain Metastases Diagnosis

KalkineOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS

TradingViewOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Senate Panel Examines China's Influence on U.S. Drug Supply Chain

Legis1Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

News | DivcoWest lands biotech headquarters deal at revamped Boston tower

CoStarOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

On the run for 20 years, most-wanted fugitive caught hiding as a biotech exec

Ars TechnicaOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

Investing News NetworkOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

AI toxicity prediction: What machine learning models can (and can't) tell you about drug safety

Drug Discovery NewsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FDA's action plan for AI in drug development: What scientists need to know

Drug Discovery NewsOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Threading AI Throughout the Drug Development Lifecycle: An Enterprise Lens

Fierce BiotechOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Kansas City’s biotech industry gets boost with $38.1M in federal funding

KSHB 41 Kansas CityOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Korea’s Kolon TissueGene shares hit 9-month low after knee therapy fails US phase 3 trial

KED GlobalOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Peptides: FDA May Ease Restrictions Despite Concerns From Experts

HealthlineOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

FDA Faces Staffing Crisis Threatening U.S. Drug Innovation

Legis1Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene's TG-C Fails US Phase 3 Trial, Stock Hits Limit Down; K-Bio Trust Plummets

finance.biggo.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Nurix to Receive $700M Upfront in Roche Bexobrutideg Deal

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Celldex Drug Depleted Mast Cells but Did Not Ease PN Itch

Stock TitanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Global clinical trial testing Huntington’s pill to open in 3 new countries

huntingtonsdiseasenews.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Gov. Shapiro announces biotech initiative in West Philadelphia

WHYYOriginal source

🇺🇰Jul 22Regulatorygov.ukTier 1 · Regulatory source

Precautionary medical evacuation following a potential healthcare related exposure to Ebola

The UK government has worked with the NHS, the government of the Democratic Republic of the Congo (D...

UK Health Security AgencyOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Frontier Bio Wins Phase 1 of $7M NIH Challenge for AI-Powered Blood-Brain Barrier Testing

The TennesseanOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The Blueprint for a Bigger Medical Bureaucracy, Part 3: News Article

Independent InstituteOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance

Business Insider AfricaOriginal source

🇺🇸Jul 22Devicesopsb.comTier 3 · Secondary coverage

DF2® Brace

OrthoPediatricsOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

How to interpret clinical trial results for Long COVID

The Sick TimesOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Marijuana Rescheduling-Fake News Doesn't Want The Public To Know- ALJ Hearing Gone Wrong

Newswire.comOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Danaher’s revenue outlook cut, biotech miss overshadow profit forecast raise

1470 & 100.3 WMBDOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

The U.S.-China Biotech Race Has Begun

RealClearHealthOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Why Some Scientists Are Worried About the Peptide Boom

MedShadow FoundationOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Daphne Koller on Why Insitro Skipped Biotech’s Shortcut

observer.comOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’

BioPharma DiveOriginal source

🇺🇸Jul 22Industrytechcyte.comTier 1 · Company source

Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform

TechcyteOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Is Lettuce Safe to Eat? The Latest on the Cyclosporiasis Outbreak

Time MagazineOriginal source

🌍Jul 22Regulatorycssp.gob.svTier 1 · Regulatory source

Programa Anual de Regulación de Establecimientos de Salud del Sector Privado 2026

Consejo Superior de Salud Pública (El Salvador)Original source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Biotech IPOs lead 2026 US market, overshadowing AI firms like Anthropic

Crypto BriefingOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis

CORDISOriginal source

🌍Jul 22discoverynews.google.comTier 2 · Trade media

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

BioPharma DiveOriginal source

🇺🇰Jul 22Regulatorygov.ukTier 1 · Regulatory source

Influenza vaccines marketed in the UK

Influenza vaccines marketed in the UK for 2026 to 2027, including ovalbumin content.

UK Health Security AgencyOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Inside Semmelweis: Doceree's AI Bet on Pharma Marketing

Pharmaceutical CommerceOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: conect4children (COllaborative Network for European Clinical Trials For Children)

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Stem-cell based gene therapy for recombination deficient SCID (RECOMB)

CORDISOriginal source

🇪🇺Jul 22Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

CORDISOriginal source

🌍Jul 22discoverynews.google.comTier 3 · Aggregated media

Newly upgraded One Lincoln tower lands its first biotech tenant

The Boston GlobeOriginal source

🇺🇰Jul 22Regulatorygov.ukTier 1 · Regulatory source

National mycobacterium reference service - South: user handbook

How to label, package and submit specimens to the laboratory for diagnostic testing.

UK Health Security AgencyOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Mid-Year Check-In: Has Pharma's Commercial Caution Lifted?

Pharmaceutical CommerceOriginal source

🌍Jul 21discoverynews.google.comTier 2 · Trade media

Why Japan is a global destination for regenerative medicine

Pharmaceutical TechnologyOriginal source

🇺🇸Jul 21Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Medicine study finds women experience more severe neurological symptoms of long COVID than men

Northwestern MedicineOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

New Bill: Senator Elizabeth Warren introduces S. 4987: Pharmaceutical Investment Oversight and Accountability Act

Quiver QuantitativeOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Masimo keeps $634m smartwatch award and moves to appeal

Life Sciences IP ReviewOriginal source

🌍Jul 21discoverynews.google.comTier 2 · Trade media

Novo sues Lilly after alleged misleading and false advertising campaign

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 21Regulatorygov.ukTier 1 · Regulatory source

Bacteriology reference department user manual

A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services it...

UK Health Security AgencyOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Sepul Bio Completes Enrollment in Phase 2b LUNA Clinical Trial of Ultevursen for USH2A-Associated Retinitis Pigmentosa

PA MediaOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Biotech IPO Gains Crush AI Listings With Standout 55% Return

Advisor PerspectivesOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Why Is AGIO Stock Falling Today?

TradingViewOriginal source